SELLAS Life Sciences SLS
NASDAQ SLS
$11.35 -0.79 (-6.51%)
At close: Oct 22, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) EV to FCF (2017)

Updated

SELLAS Life Sciences' EV to FCF came in at 26.94 for Q3 2017, down 74.5% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) EV to FCF (2017) Analysis & Trends

Over the trailing twelve months to Sep 30, 2017, SELLAS Life Sciences reported EV to FCF of 24.27.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 SELLAS Life Sciences 2.14 Bn 1.78 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 26.94
Jun 30, 2017 105.46
API Access

SELLAS Life Sciences EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SLS&period=max&api_key=YOUR_API_KEY